$0.00
(+0.00%
) Quote details
USD
+$0.00
(+0.00%
)At Close (As of Dec 3, 2025)
$45.05M
Market Cap
-
P/E Ratio
-9.29
EPS
$9.26
52 Week High
$1.17
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
BioXcel Therapeutics Inc. is an innovative clinical-phase biopharmaceutical company based in New Haven, Connecticut, specializing in harnessing artificial intelligence to revolutionize drug discovery and development, particularly in the fields of neuroscience and immuno-oncology. The company boasts a promising pipeline of therapies designed to address significant unmet medical needs, emphasizing its commitment to transforming patient care through novel therapeutics. By integrating state-of-the-art AI technologies with extensive scientific expertise, BioXcel is strategically positioned to lead advancements in an evolving healthcare landscape, making it an attractive consideration for institutional investors.
LPTX
NVDA
VHAI
PLUG
BITF
IPG
AAL
ASST
F
ADAP
WBD
MARA
BAC
DNN
PFE
NIO
AMD
CAN
CLSK
MRVL
IVP
ITUB
CIFR
GOOGL
PLTR
GRAB
APLD
MSTR
PLTD
VALE
EB
RGTI
ASBP
MTSR
RIG
NFLX
PCG
HOOD
GOOG
VICI
VZ
TMC
BA
AG
AVGO
RIOT
STLA
NOK
LUMN
QBTS
AMCR
ORCL
MSFT
CGC
SMCI
SMR
UBER
EOSE
TSLG
CCL
IQ
ALAB
RXRX
JOBY
AMC
AEO
CRDO
HPE
LPTX
NVDA
VHAI
PLUG
BITF
IPG
AAL
ASST
F
ADAP
WBD
MARA
BAC
DNN
PFE
NIO
AMD
CAN
CLSK
MRVL
IVP
ITUB
CIFR
GOOGL
PLTR
GRAB
APLD
MSTR
PLTD
VALE
EB
RGTI
ASBP
MTSR
RIG
NFLX
PCG
HOOD
GOOG
VICI
VZ
TMC
BA
AG
AVGO
RIOT
STLA
NOK
LUMN
QBTS
AMCR
ORCL
MSFT
CGC
SMCI
SMR
UBER
EOSE
TSLG
CCL
IQ
ALAB
RXRX
JOBY
AMC
AEO
CRDO
HPE